Curis Inc. said its board approved a 1-for-5 reverse split of its common stock.
The Lexington, Mass.-based biotechnology company said the split is expected to become effective on May 29 after close of trading.
The shares will begin trading on the Nasdaq Global Market on a split-adjusted basis when the market opens on May 30.
